Instil Bio, Inc. Cash Flow Statement
TIL|1 years of annual SEC 10-K data (FY2021-FY2021)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid. All figures from audited SEC 10-K filings.
Instil Bio, Inc. used $30M in operating cash flow and negative free cash flow of $80M in FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.30 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 |
|---|---|
| Net Income | -$37.7M |
| Depreciation & Amortization | $256.0K |
| Operating Cash Flow | -$29.6M |
| Capital Expenditures | $50.8M |
| Free Cash Flow | -$80.4M |
| FCF Margin | -58284.1% |